Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Analyst Ratings

Analyst Ratings

Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • Initiation
  • Movers
  • News
  • Price Target
  • Trading Ideas

Credit Suisse Initiates Coverage On Mosaic, Sees Notable Upside

By Akanksha Bakshi
July 14, 2:49 PM
Credit Suisse analyst John Roberts initiated coverage of Mosaic Co (NYSE:MOS) with an Outperform rating and a price target of $60, implying an…

MOS

Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • Biotech
  • General
  • Health Care
  • Initiation
  • Movers
  • News
  • Price Target
  • Trading Ideas

SVB Likes This ‘Novel Antipsychotic’-Focused Stock

By Vandana Singh
July 14, 2:49 PM
SVB Leerink initiated coverage on Karuna Therapeutics Inc (NASDAQ:KRTX) with an Outperform rating and a price target of $170. SVB notes that…

KRTX

Read More
1 minute read
  • Analyst Ratings

Expert Ratings for Seagate Tech Hldgs

By Benzinga Insights
July 14, 1:21 PM
Seagate Tech Hldgs (NASDAQ:STX) has observed the following analyst ratings within the last quarter:

STX

Read More
1 minute read
  • Analyst Ratings

What 5 Analyst Ratings Have To Say About CarMax

By Benzinga Insights
July 14, 1:21 PM
Analysts have provided the following ratings for CarMax (NYSE:KMX) within the last quarter:

KMX

Read More
2 minute read
  • Analyst Ratings

What 4 Analyst Ratings Have To Say About PerkinElmer

By Benzinga Insights
July 14, 1:20 PM
Analysts have provided the following ratings for PerkinElmer (NYSE:PKI) within the last quarter:

PKI

Read More
2 minute read
  • Analyst Ratings

Analyst Ratings for Booking Holdings

By Benzinga Insights
July 14, 1:20 PM
Within the last quarter, Booking Holdings (NASDAQ:BKNG) has observed the following analyst ratings:

BKNG

Read More
1 minute read
  • Analyst Ratings

5 Analysts Have This to Say About Enphase Energy

By Benzinga Insights
July 14, 1:19 PM
Analysts have provided the following ratings for Enphase Energy (NASDAQ:ENPH) within the last quarter:

ENPH

Read More
2 minute read
  • Analyst Ratings

What 10 Analyst Ratings Have To Say About Centene

By Benzinga Insights
July 14, 1:19 PM
Analysts have provided the following ratings for Centene (NYSE:CNC) within the last quarter:

CNC

Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • News
  • Price Target
  • Reiteration

RBC Capital Cuts Boeing Price Target By 9%

By Akanksha Bakshi
July 14, 12:53 PM
RBC Capital analyst Ken Herbert lowered the price target on Boeing Co (NYSE:BA) to $200 (39% upside) from $220 while maintaining the Outperform…

BA

Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target

Goldman Sachs Maintains Buy on WalkMe, Lowers Price Target to $14

By Benzinga Newsdesk
July 14, 12:12 PM
Goldman Sachs maintains WalkMe (NASDAQ:WKME) with a Buy and lowers the price target from $18 to $14.

WKME

Posts pagination

Previous 1 … 4,289 4,290 4,291 … 4,420 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service